NCT01312766View on ClinicalTrials.gov

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

December 31, 2013

Conditions
Infertility
Interventions
DRUG

Menotropins

Daily administration, SC, starting dose 150 IU or 225 IU depending on patient age.

DRUG

Menotropins

Daily administration, SC, starting dose 150 IU or 225 IU depending on patient age.

Trial Locations (6)

1088

First Dept. Obstetric and Gynaecology, Semmelweiss University, Budapest

2650

Fertility clinic at Hvidovre Hospital, Hvidovre

4031

Universitätsspital Basel, Basel

5000

Odense Universitetshospital, Odense

75014

Groupe Hospitalier Cochin - Saint Vincent de Paul, Paris

WS9 8LT

Midland Fertility Services, Aldridge

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT01312766 - Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients | Biotech Hunter | Biotech Hunter